Cue Biopharma, Inc. (NASDAQ:CUE) Sees Large Growth in Short Interest

Cue Biopharma, Inc. (NASDAQ:CUE – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 4,780,000 shares, an increase of 13.8% from the March 31st total of 4,200,000 shares. Based on an average trading volume of 256,300 shares, the short-interest ratio […]

Related Keywords

California ,United States ,Stifel Nicolaus ,Piper Sandler ,Sigma Planning Corp ,Nasdaq ,Jefferies Financial Group ,Cue Biopharma Inc ,Legacy Capital Group California Inc ,Cue Biopharma ,Get Free Report ,Private Capital ,Capital Group California ,Planning Corp ,Financial Group ,Cue Biopharma Daily ,Nasdaq Cue ,Cue ,Medical ,Stocks ,Options ,Put ,Call ,